These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 4393073)

  • 1. Pharmacologic properties and mechanism of action of amfonelic acid.
    Aceto MD; Botton I; Martin R; Levitt M; Bentley HC; Speight PT
    Eur J Pharmacol; 1970; 10(3):344-54. PubMed ID: 4393073
    [No Abstract]   [Full Text] [Related]  

  • 2. Divergent reserpine effects on amfonelic acid and amphetamine stimulation of synaptosomal dopamine formation from phenylalanine.
    Bagchi SP; Smith TM; Bagchi P
    Biochem Pharmacol; 1980 Nov; 29(21):2957-62. PubMed ID: 6109534
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral effects of amfonelic acid in rats: a comparison with amphetamine and apomorphine.
    Jeste DV; Perlow MJ; Wyatt RJ; Stoff DM
    Commun Psychopharmacol; 1979; 3(1):41-7. PubMed ID: 38031
    [No Abstract]   [Full Text] [Related]  

  • 4. Amfonelic acid antagonism of dopamine and norepinephrine depletion by alpha-methyl-m-tyrosine in rat brain.
    Fuller RW; Perry KW
    Biochem Pharmacol; 1981 Jul; 30(14):2025-6. PubMed ID: 7271892
    [No Abstract]   [Full Text] [Related]  

  • 5. Amfonelic acid, a non-amphetamine stimulant, has marked effects on brain dopamine metabolism but not noradrenaline metabolism: association with differences in neuronal storage systems.
    McMillen BA; Shore PA
    J Pharm Pharmacol; 1978 Jul; 30(7):464-6. PubMed ID: 27622
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity.
    Andén NE; Strömbom U
    Psychopharmacologia; 1974; 38(2):91-103. PubMed ID: 4533319
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA; Moore KE
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacologic studies with 7-benzyl-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid.
    Aceto MD; Harris LS; Lesher GY; Pearl J; Brown TG
    J Pharmacol Exp Ther; 1967 Nov; 158(2):286-93. PubMed ID: 4383638
    [No Abstract]   [Full Text] [Related]  

  • 10. Tyrosine hydroxylase inhibitors.
    Moore KE; Dominic JA
    Fed Proc; 1971; 30(3):859-70. PubMed ID: 4324974
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of catecholamines in the central effects of amphetamine.
    Pfeifer AK; György L; Fodor M
    Acta Med Acad Sci Hung; 1968; 25(3):441-50. PubMed ID: 5720870
    [No Abstract]   [Full Text] [Related]  

  • 12. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
    Segal DS; McAllister C; Geyer MA
    Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
    Cooper BR; Grant LD; Breese GR
    Psychopharmacologia; 1973 Jul; 31(2):95-109. PubMed ID: 4722209
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
    Ahlenius S
    Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
    Rech RH; Carr LA; Moore KE
    J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
    [No Abstract]   [Full Text] [Related]  

  • 16. Stimulus-dependent antagonism of the alpha-methyltyrosine-induced lowering of brain catecholamines by (+)-amphetamine in intact mice.
    Welch BL; Welch AS
    J Pharm Pharmacol; 1967 Dec; 19(12):841-3. PubMed ID: 4384230
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain.
    Scheel-Krüger J
    Eur J Pharmacol; 1971; 14(1):47-59. PubMed ID: 4396660
    [No Abstract]   [Full Text] [Related]  

  • 18. Brain catecholamines and the reserpine-induced stimulation of the pituitary-adrenal system.
    Hirsch GH; Moore KE
    Neuroendocrinology; 1968; 3(6):398-405. PubMed ID: 4388076
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 20. Brain dopamine and the amphetamine-reserpine interaction.
    Randrup A; Jonas W
    J Pharm Pharmacol; 1967 Jul; 19(7):483-4. PubMed ID: 4382645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.